Our present study demonstrated for the first time that treatment with AFC1 compound effectively attenuates MI/R-induced cardiac remodeling, accompanied by decreased PDGFR expression, oxidative stress, and inflammatory response in hearts post MI/R. This evidence concerns the gene PDGFRB and myocardial infarction.